1. Home
  2. PHK vs LENZ Comparison

PHK vs LENZ Comparison

Compare PHK & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHK
  • LENZ
  • Stock Information
  • Founded
  • PHK 2003
  • LENZ 2019
  • Country
  • PHK United States
  • LENZ United States
  • Employees
  • PHK N/A
  • LENZ N/A
  • Industry
  • PHK Finance/Investors Services
  • LENZ Medicinal Chemicals and Botanical Products
  • Sector
  • PHK Finance
  • LENZ Health Care
  • Exchange
  • PHK Nasdaq
  • LENZ Nasdaq
  • Market Cap
  • PHK 831.7M
  • LENZ 886.0M
  • IPO Year
  • PHK N/A
  • LENZ 2021
  • Fundamental
  • Price
  • PHK $4.88
  • LENZ $37.85
  • Analyst Decision
  • PHK
  • LENZ Strong Buy
  • Analyst Count
  • PHK 0
  • LENZ 4
  • Target Price
  • PHK N/A
  • LENZ $49.75
  • AVG Volume (30 Days)
  • PHK 491.5K
  • LENZ 648.2K
  • Earning Date
  • PHK 01-01-0001
  • LENZ 07-30-2025
  • Dividend Yield
  • PHK 12.61%
  • LENZ N/A
  • EPS Growth
  • PHK N/A
  • LENZ N/A
  • EPS
  • PHK N/A
  • LENZ N/A
  • Revenue
  • PHK N/A
  • LENZ $5,000,000.00
  • Revenue This Year
  • PHK N/A
  • LENZ N/A
  • Revenue Next Year
  • PHK N/A
  • LENZ $556.26
  • P/E Ratio
  • PHK N/A
  • LENZ N/A
  • Revenue Growth
  • PHK N/A
  • LENZ N/A
  • 52 Week Low
  • PHK $4.13
  • LENZ $16.54
  • 52 Week High
  • PHK $5.15
  • LENZ $41.70
  • Technical
  • Relative Strength Index (RSI)
  • PHK 52.75
  • LENZ 60.20
  • Support Level
  • PHK $4.81
  • LENZ $34.88
  • Resistance Level
  • PHK $4.91
  • LENZ $40.95
  • Average True Range (ATR)
  • PHK 0.03
  • LENZ 2.90
  • MACD
  • PHK -0.01
  • LENZ 0.84
  • Stochastic Oscillator
  • PHK 26.92
  • LENZ 72.32

About PHK Pimco High Income Fund

PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: